This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Michigan State University, University of Michigan. Active years: 2020.
Company Filing History:
1 out of 1,437 
1 out of 3,519 
Years Active: 2020
Title: The Innovations of Andrew Haak
Introduction
Andrew Haak is an accomplished inventor based in Rochester, MN (US). He has made significant contributions to the field of gene transcription, particularly in relation to cancer and fibrosis. His innovative work has led to the development of a patent that addresses critical medical challenges.
Latest Patents
Andrew Haak holds a patent titled "Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same." This patent discloses inhibitors of gene transcription mediated by myocardin-related transcription factor and serum response factor, or both. The compounds described in the patent are aimed at treating or preventing cancer and fibrosis, showcasing the potential impact of his work on medical therapies.
Career Highlights
Throughout his career, Andrew has worked with prestigious institutions such as Michigan State University and the University of Michigan. His experience in these academic environments has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.
Collaborations
Andrew has collaborated with notable colleagues, including Erika Mathes Lisabeth and Walajapet Rajeswaran. These partnerships have enriched his research and expanded the scope of his innovations.
Conclusion
Andrew Haak's contributions to the field of gene transcription and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of serious health conditions.